RT Journal Article SR Electronic T1 Non-invasively measured brain activity and radiological progression in diffuse glioma JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.31.21250524 DO 10.1101/2021.01.31.21250524 A1 T. Numan A1 S.D. Kulik A1 B. Moraal A1 J.C. Reijneveld A1 CJ. Stam A1 P.C. de Witt Hamer A1 J. Derks A1 A.M.E. Bruynzeel A1 M.E. van Linde A1 P. Wesseling A1 M.C.M. Kouwenhoven A1 M. Klein A1 T. Würdinger A1 F. Barkhof A1 J.J.G. Geurts A1 A. Hillebrand A1 L. Douw YR 2021 UL http://medrxiv.org/content/early/2021/02/03/2021.01.31.21250524.abstract AB Non-invasively measured brain activity is related to progression-free survival in glioma patients, suggesting its potential as a marker of glioma progression. We therefore assessed the relationship between brain activity and increasing tumor volumes on routine clinical magnetic resonance imaging (MRI) in glioma patients. Postoperative magnetoencephalography (MEG) was recorded in 45 diffuse glioma patients. Brain activity was estimated using three measures (absolute broadband power, offset and slope) calculated at three spatial levels: global average, averaged across the peritumoral areas, and averaged across the homologues of these peritumoral areas in the contralateral hemisphere. Tumors were segmented on MRI. Changes in tumor volume between the two scans surrounding the MEG were calculated and correlated with brain activity. Brain activity was compared between patient groups classified into having increasing or stable tumor volume. Results show that brain activity was significantly increased in the tumor hemisphere in general, and in peritumoral regions specifically. However, none of the measures and spatial levels of brain activity correlated with changes in tumor volume, nor did they differ between patients with increasing versus stable tumor volumes. Longitudinal studies in more homogeneous subgroups of glioma patients are necessary to further explore the clinical potential of non-invasively measured brain activity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Cancer Center Amsterdam foundation, the Dutch Epilepsy Foundation (NEF, Grants 08-08 and 09-09), the Dutch MS Research Foundation (Grant 09-358d), the Netherlands Organization for Scientific Research (NWO-ZonMW Veni 016.146.086 and NWO-ENW Vidi 198.015) and Society in Science (Branco Weiss Fellowship).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the VU University Medical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. Our final code will be made available through GitHub to allow broader use, although we note that we made use of already publicly available code for all main analyses.